Common invasive test not necessary for kidney disease patients

Equations that estimate a patient's kidney function work as well as direct, invasive measurements, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). This means that many patients with chronic kidney disease (CKD) do not need to undergo the painful and cumbersome procedures that are performed to monitor kidneys' health.

Measuring CKD patients' kidney function can help physicians anticipate complications and provide optimal treatments. Most measures focus on patients' (GFR), or the rate that the kidneys filter wastes from the urine. Clinicians have traditionally assumed that directly testing GFR by injecting a tracer agent such as iothalamate provides a better measure of kidney function than calculating GFR indirectly with an equation. However, iothalamate GFR (iGFR) is more cumbersome and invasive than equation-estimated GFR (eGFR). Specifically, iGFR involves injecting a (sometimes radioactive) agent, taking multiple blood samples, and doing timed urine collections, while eGFR involves one simple blood test.

To compare the tests, Chi-yuan Hsu, MD (University of California, San Francisco) and his colleagues looked to see which is more strongly and consistently linked with common CKD complications in 1,214 CKD patients who participated in the Chronic Renal Insufficiency Cohort (CRIC) study, which includes the largest ever group of CKD patients assembled and is sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases.

The investigators found that eGFR linked just as tightly to CKD complications as iGFR. These results refute the conventional view that iGFR is in fact the gold standard measure of . "For many purposes and for many patients, relying on equations to estimate GFR alone may be sufficient, and patients can avoid undergoing more invasive assays to directly measure GFR," said Dr. Hsu.

More information: The article, entitled "Is iGFR Really Better than eGFR? Analyzing Associations with Common Co-morbid Conditions," will appear online at doi 10.1681/ASN.2010101077
Citation: Common invasive test not necessary for kidney disease patients (2011, September 15) retrieved 13 October 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more